2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Urinary Bladder Neoplasms
1
Trigeminal Neuralgia
1
Spinal Stenosis
1
Spinal Fractures
1
Spinal Diseases
1
Spinal Curvatures
1
Spinal Cord Neoplasms
1
Prostatic Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Hydrocephalus
1
Brain Neoplasms
1
Brain Diseases
1
Aneurysm
1
Interventions
Temozolomide
10
Radiotherapy
5
Carboplatin
5
Vincristine
4
Radiosurgery
4
Surveys and Questionnaires
3
Magnetic Resonance Imaging
3
Etoposide
3
Bevacizumab
3
etoposide phosphate
2
Vorinostat
2
Magnetic Resonance Spectroscopy
2
Lomustine
2
Irinotecan
2
Immunoglobulin G
2
Ifosfamide
2
Fluorodeoxyglucose F18
2
Disulfides
2
Cisplatin
2
veliparib
1
tozuleristide
1
romidepsin
1
perillyl alcohol
1
pembrolizumab
1
olutasidenib
1
lonafarnib
1
ispinesib
1
emvododstat
1
cediranib
1
abemaciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Spinal Cord Neoplasms
×
Patient Discharge
×
Clear all
NCT03593330
2025-05-02
TCP
Barts & The London NHS Trust
Phase NA
Terminated
242 enrolled